Search research articles
Contact Us
Filters
Showing results (91-100 of 127) with videos related to
Page
of 13
Sort By:
Developmental Cognitive Neuroscience
|
September 15, 2015
Short-term test-retest reliability of resting state fMRI metrics in children with and without attention-deficit/hyperactivity disorder
Krishna Somandepalli, Clare Kelly, Philip T Reiss, et al.
Blood
|
March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
E Olavarria, E Kanfer, R Szydlo, et al.
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology
|
February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis
C Craddock, R M Szydlo, F Dazzi, et al.
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Bone Marrow Transplantation
|
February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study
W A Stewart, R Pearce, K E Kirkland, et al.
Bone Marrow Transplantation
|
October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT
J Loke, M Labopin, C Craddock, et al.
Journal of Hematology & Oncology
|
January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Simona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation
|
May 4, 2006
Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005
R F Duarte, D Pamphilon, J Cornish, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 127) with videos related to
Sort By:
Page
of 13
Developmental Cognitive Neuroscience
|
September 15, 2015
Short-term test-retest reliability of resting state fMRI metrics in children with and without attention-deficit/hyperactivity disorder
Krishna Somandepalli, Clare Kelly, Philip T Reiss, et al.
Blood
|
March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
E Olavarria, E Kanfer, R Szydlo, et al.
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology
|
February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis
C Craddock, R M Szydlo, F Dazzi, et al.
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Bone Marrow Transplantation
|
February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study
W A Stewart, R Pearce, K E Kirkland, et al.
Bone Marrow Transplantation
|
October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT
J Loke, M Labopin, C Craddock, et al.
Journal of Hematology & Oncology
|
January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Simona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation
|
May 4, 2006
Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005
R F Duarte, D Pamphilon, J Cornish, et al.
Page
of 13